Li, H, Engel, C, de la Hoya, M, Peterlongo, P, Yannoukakos, D, Livraghi, L, Radice, P, Thomassen, M, Hansen, T V O, Gerdes, A-M, Nielsen, H R, Caputo, S M, Zambelli, A, Borg, A, Solano, A, Thomas, A, Parsons, M T, Antoniou, A C, Leslie, G, Yang, X, Chenevix-Trench, G, Caldes, T, Kwong, A, Pedersen, I S, Lautrup, C K, John, E M, Terry, M B, Hopper, J L, Southey, M C, Andrulis, I L, Tischkowitz, M, Janavicius, R, Boonen, S E, Kroeldrup, L, Varesco, L, Hamann, U, Vega, A, Palmero, E I, Garber, J, Montagna, M, Van Asperen, C J, Foretova, L, Greene, M H, Selkirk, T, Moller, P, Toland, A E, Domchek, S M, James, P A, Thorne, H, Eccles, D M, Nielsen, S M, Manoukian, S, Pasini, B, Caligo, M A, Lazaro, C, Kirk, J, Wappenschmidt, B, Spurdle, A B, Couch, F J, Schmutzler, R, Goldgar, D E, ENIGMA consortium & CIMBA Consortium 2022, ' Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants ', Genetics in Medicine, vol. 24, no. 1, pp. 119-129 . https://doi.org/10.1016/j.gim.2021.08.016 Genet Med Genetics in Medicine, 24(1), 119-129. ELSEVIER SCIENCE INC ENIGMA Consortium 2022, ' Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants ', Genetics in Medicine, vol. 24, no. 1, pp. 119-129 . https://doi.org/10.1016/j.gim.2021.08.016 Goldgar, D E, ENIGMA Consortium & CIMBA Consortium 2022, ' Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants ', Genetics in Medicine, vol. 24, no. 1, pp. 119-129 . https://doi.org/10.1016/j.gim.2021.08.016
Barnes, D R, Silvestri, V, Leslie, G, McGuffog, L, Dennis, J, Yang, X, Adlard, J, Agnarsson, B A, Ahmed, M, Aittomäki, K, Andrulis, I L, Arason, A, Arnold, N, Auber, B, Azzollini, J, Balmaña, J, Barkardottir, R B, Barrowdale, D, Barwell, J, Belotti, M, Benitez, J, Berthet, P, Boonen, S E, Borg, Å, Bozsik, A, Brady, A F, Brennan, P, Brewer, C, Brunet, J, Bucalo, A, Buys, S S, Caldés, T, Caligo, M A, Campbell, I, Cassingham, H, Christensen, L L, Cini, G, Claes, K B M, Cook, J, Coppa, A, Cortesi, L, Damante, G, Darder, E, Davidson, R, de la Hoya, M, Hansen, T V O, Horvath, J, Jensen, U B, Lautrup, C, Pedersen, I S & GEMO Study Collaborators 2022, ' Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores ', Journal of the National Cancer Institute, vol. 114, no. 1, 147, pp. 109-122 . https://doi.org/10.1093/jnci/djab147 JNCI Journal of the National Cancer Institute Barnes, D R, Silvestri, V, Leslie, G, McGuffog, L, Dennis, J, Yang, X, Adlard, J, Agnarsson, B A, Ahmed, M, Aittomäki, K, Andrulis, I L, Arason, A, Arnold, N, Auber, B, Azzollini, J, Balmaña, J, Barkardottir, R B, Barrowdale, D, Barwell, J, Belotti, M, Benitez, J, Berthet, P, Boonen, S E, Borg, Å, Bozsik, A, Brady, A F, Brennan, P, Brewer, C, Brunet, J, Bucalo, A, Buys, S S, Caldés, T, Caligo, M A, Campbell, I, Cassingham, H, Christensen, L L, Cini, G, Claes, K B M, Cook, J, Coppa, A, Cortesi, L, Damante, G, Darder, E, Davidson, R, de la Hoya, M, De Leeneer, K, de Putter, R, Del Valle, J, Diez, O, Ding, Y C, Domchek, S M, Donaldson, A, Eason, J, Eeles, R, Engel, C, Evans, D G, Feliubadaló, L, Fostira, F, Frone, M, Frost, D, Gallagher, D, Gehrig, A, Giraud, S, Glendon, G, Godwin, A K, Goldgar, D E, Greene, M H, Gregory, H, Gross, E, Hahnen, E, Hamann, U, Hansen, T V O, Hanson, H, Hentschel, J, Horvath, J, Izatt, L, Izquierdo, A, James, P A, Janavicius, R, Jensen, U B, Johannsson, O T, John, E M, Kramer, G, Kroeldrup, L, Kruse, T A, Lautrup, C, Lazaro, C, Lesueur, F, Lopez-Fernández, A, Mai, P L, Manoukian, S, Matrai, Z, Matricardi, L, Maxwell, K N, Mebirouk, N, Meindl, A, Montagna, M, Monteiro, A N, Morrison, P J, Muranen, T A, Murray, A, Nathanson, K L, Neuhausen, S L, Nevanlinna, H, Nguyen-Dumont, T, Niederacher, D, Olah, E, Olopade, O I, Palli, D, Parsons, M T, Pedersen, I S, Peissel, B, Perez-Segura, P, Peterlongo, P, Petersen, A H, Pinto, P, Porteous, M E, Pottinger, C, Pujana, M A, Radice, P, Ramser, J, Rantala, J, Robson, M, Rogers, M T, Rønlund, K, Rump, A, Sánchez de Abajo, A M, Shah, P D, Sharif, S, Side, L E, Singer, C F, Stadler, Z, Steele, L, Stoppa-Lyonnet, D, Sutter, C, Tan, Y Y, Teixeira, M R, Teulé, A, Thull, D L, Tischkowitz, M, Toland, A E, Tommasi, S, Toss, A, Trainer, A H, Tripathi, V, Valentini, V, van Asperen, C J, Venturelli, M, Viel, A, Vijai, J, Walker, L, Wang-Gohrke, S, Wappenschmidt, B, Whaite, A, Zanna, I, Offit, K, Thomassen, M, Couch, F J, Schmutzler, R K, Simard, J, Easton, D F, Chenevix-Trench, G, Antoniou, A C, Ottini, L & GEMO Study Collaborators 2022, ' Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores ', Journal of the National Cancer Institute, vol. 114, no. 1, pp. 109-122 . https://doi.org/10.1093/jnci/djab147 JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE Dipòsit Digital de la UB Universidad de Barcelona Journal of the National Cancer Institute, 114(1), 109-122. OXFORD UNIV PRESS INC JNCI-Journal of the National Cancer Institute, Oxford : Oxford University Press, 2022, vol. 114, iss. 1, p. 109-122 GEMO Study Collaborators, EMBRACE Collaborators, kConFab Investigators, HEBON Investigators, BRCA1 & BRCA2 2022, ' Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores ', National Cancer Institute. Journal (Online), vol. 114, no. 1, 147, pp. 109-122 . https://doi.org/10.1093/jnci/djab147 Scientia GEMO Study Collaborators, Kristensen, L K, Jensen, U B, Lautrup, C K & Høgh Petersen, A 2022, ' Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores ', National Cancer Institute. Journal (Online), vol. 114, no. 1, djab147, pp. 109-122 . https://doi.org/10.1093/jnci/djab147
Dipòsit Digital de la UB Universidad de Barcelona Nature Genetics, 52(6), 572-581. Nature Publishing Group Nature Genetics, 52(6), 572-581. NATURE RESEARCH Zhang, H, Ahearn, T U, Lecarpentier, J, Barnes, D, Beesley, J, Qi, G, Jiang, X, O’Mara, T A, Zhao, N, Bolla, M K, Dunning, A M, Dennis, J, Wang, Q, Ful, Z A, Aittomäki, K, Andrulis, I L, Anton-Culver, H, Arndt, V, Aronson, K J, Arun, B K, Auer, P L, Azzollini, J, Barrowdale, D, Becher, H, Beckmann, M W, Behrens, S, Benitez, J, Bermisheva, M, Bialkowska, K, Blanco, A, Blomqvist, C, Bogdanova, N V, Bojesen, S E, Bonanni, B, Bondavalli, D, Borg, A, Brauch, H, Brenner, H, Briceno, I, Broeks, A, Brucker, S Y, Brüning, T, Burwinkel, B, Buys, S S, Byers, H, Caldés, T, Caligo, M A, Christiansen, H, Laenkholm, A V, Nielsen, F C, Thomassen, M, kConFab Investigators, ABCTB Investigators, EMBRACE Study & GEMO Study Collaborators 2020, ' Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses ', Nature Genetics, vol. 52, no. 6, pp. 572-581 . https://doi.org/10.1038/s41588-020-0609-2 2020, ' Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses ', Nature Genetics . https://doi.org/10.1038/s41588-020-0609-2 Nature Genetics